Allison Grenell

Allison Grenell

Auto-generated profile, based on publicly available information

Allison Grenell

Ophthalmic Research, Cole Eye Institute, Cleveland Clinic, Cleveland, OH 44195, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2019 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
AGAllison Grenell
Allison Grenell
YWYekai Wang
Yekai Wang
MYMichelle Yam
Michelle Yam
ASAditi Swarup
Aditi Swarup
TDTanya L. Dilan
Tanya L. Dilan
JDJianhai Du
Jianhai Du
Glucose metabolism in vertebrate retinas is dominated by aerobic glycolysis (the “Warburg Effect”), which allows only a small fraction of glucose-derived pyruvate to enter mitochondria. Here, we report evidence that the small fraction of pyruvate in photoreceptors that does get oxidized by their mitochondria is required for visual function, photoreceptor structure and viability, normal neuron–glial interaction, and homeostasis of retinal metabolism. The mitochondrial pyruvate carrier (MPC) links glycolysis and mitochondrial metabolism. Retina-specific deletion of MPC1 results in progressive retinal degeneration and decline of visual function in both rod and cone photoreceptors. Using targeted-metabolomics and 13C tracers, we found that MPC1 is required for cytosolic reducing power maintenance, glutamine/glutamate metabolism, and flexibility in fuel utilization. Significance Mitochondrial pyruvate carrier (MPC) is responsible for transporting pyruvate from glycolysis into mitochondria for oxidative phosphorylation. In the vertebrate retinas, the majority of glucose is metabolized into lactate by glycolysis rather than being oxidized in the mitochondria. Here, we show that although a small percentage of glucose is transported through MPC, deletion of MPC impairs visual function, decreases the viability of photoreceptors, disrupts photoreceptor ultrastructure, and causes glial activation. We find that MPC is required for maintaining the retinal metabolism in amino acids, neurotransmitters, and ketone bodies.

1 November 2018 in Neurobiology of Aging
Verified
Journal Article
Closed access
YWYekai Wang
Yekai Wang
AGAllison Grenell
Allison Grenell
FZFanyi Zhong
Fanyi Zhong
MYMichelle Yam
Michelle Yam
AHAllison Hauer
Allison Hauer
JDJianhai Du
Jianhai Du

1 September 2018 in Experimental Eye Research
Verified
Journal Article
Closed access
SZSiyan Zhu
Siyan Zhu
MYMichelle Yam
Michelle Yam
YWYekai Wang
Yekai Wang
JLJonathan D. Linton
Jonathan D. Linton
AGAllison Grenell
Allison Grenell
JDJianhai Du
Jianhai Du

25 June 2021 in Life
Verified
Journal Article
Open access
PDF file
CSCharandeep Singh
Charandeep Singh
ABAndrew Benos
Andrew Benos
AGAllison Grenell
Allison Grenell
SRSujata Rao
Sujata Rao
BABela Anand-Apte
Bela Anand-Apte
JSJonathan Sears
Jonathan Sears
Oxygen supplementation is necessary to prevent mortality in severely premature infants. However, the supraphysiological concentration of oxygen utilized in these infants simultaneously creates retinovascular growth attenuation and vasoobliteration that induces the retinopathy of prematurity. Here, we report that hyperoxia regulates the cell cycle and retinal endothelial cell proliferation in a previously unknown Myc-dependent manner, which contributes to oxygen-induced retinopathy.

22 July 2024 in Molecular Metabolism
Verified
Journal Article
Open access
AGAllison Grenell
Allison Grenell
CSCharandeep Singh
Charandeep Singh
MRMonisha Raju
Monisha Raju
AWAlyson Wolk
Alyson Wolk
SDSonal Dalvi
Sonal Dalvi
BABela Anand-Apte
Bela Anand-Apte
Mutations in Tissue Inhibitor of Metalloproteinases 3 (TIMP3) cause Sorsby's Fundus Dystrophy (SFD), a dominantly inherited, rare form of macular degeneration that results in vision loss. TIMP3 is synthesized primarily by retinal pigment epithelial (RPE) cells, which constitute the outer blood-retinal barrier. One major function of RPE is the synthesis and transport of vital nutrients, such as glucose, to the retina. Recently, metabolic dysfunction in RPE cells has emerged as an important contributing factor in retinal degenerations. We set out to determine if RPE metabolic dysfunction was contributing to SFD pathogenesis. Quantitative proteomics was conducted on RPE of mice expressing the S179C variant of TIMP3, known to be causative of SFD in humans. Proteins found to be differentially expressed (P < 0.05) were analyzed using statistical overrepresentation analysis to determine enriched pathways, processes, and protein classes using g:profiler and PANTHER Gene Ontology. We examined the effects of mutant TIMP3 on RPE metabolism using human ARPE-19 cells expressing mutant S179C TIMP3 and patient-derived induced pluripotent stem cell-derived RPE (iRPE) carrying the S204C TIMP3 mutation. RPE metabolism was directly probed using isotopic tracing coupled with GC/MS analysis. Steady state [U–13C6] glucose isotopic tracing was preliminarily conducted on S179C ARPE-19 followed by [U–13C6] glucose and [U–13C5] glutamine isotopic tracing in SFD iRPE cells. Quantitative proteomics and enrichment analysis conducted on RPE of mice expressing mutant S179C TIMP3 identified differentially expressed proteins that were enriched for metabolism-related pathways and processes. Notably these results highlighted dysregulated glycolysis and glucose metabolism. Stable isotope tracing experiments with [U–13C6] glucose demonstrated enhanced glucose utilization and glycolytic activity in S179C TIMP3 APRE-19 cells. Similarly, [U–13C6] glucose tracing in SFD iRPE revealed increased glucose contribution to glycolysis and the TCA cycle. Additionally, [U–13C5] glutamine tracing found evidence of altered malic enzyme activity. This study provides important information on the dysregulation of RPE glucose metabolism in SFD and implicates a potential commonality with other retinal degenerative diseases, emphasizing RPE cellular metabolism as a therapeutic target.

6 January 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
AGAllison Grenell
Allison Grenell
CSCharandeep Singh
Charandeep Singh
MRMonisha Raju
Monisha Raju
AWAlyson Wolk
Alyson Wolk
SDSonal Dalvi
Sonal Dalvi
BABela Anand-Apte
Bela Anand-Apte
Mutations in Tissue Inhibitor of Metalloproteinases 3 (TIMP3) cause Sorsby’s Fundus Dystrophy (SFD), a dominantly inherited, rare form of macular degeneration that results in vision loss. TIMP3 is synthesized primarily by retinal pigment epithelial (RPE) cells, which constitute the outer blood-retinal barrier. Quantitative proteomics and RNAseq analysis on the choroid/RPE of mice expressing mutant TIMP3 identified a dysregulation in metabolic processes. We examined the effects of mutant TIMP3 on RPE metabolism using human ARPE-19 cells expressing mutant S179C TIMP3 and patient-derived induced pluripotent stem cell-derived RPE (iRPE) carrying the S204C TIMP3 mutation. Stable isotope tracing experiments demonstrated enhanced glucose utilization and glycolytic activity in mutant RPE concomitantly with altered glutamine utilization. This study provides important information on the dysregulation of the metabolome of RPE cells in SFD and implicates a potential commonality with other retinal degenerative diseases, emphasizing RPE cellular metabolism as a therapeutic target.